AI boom, undiagnosed TB, and the cost of innovation: Britain’s quiet reckoning

From soaring chipmaker shares to preventable deaths, Britain grapples with the human and financial toll of unchecked progress—who pays, and who profits?

AI boom, undiagnosed TB, and the cost of innovation: Britain’s quiet reckoning
Photo by Zheng XUE on Unsplash